Follow
Gabriel Léger
Gabriel Léger
Verified email at ucsd.edu - Homepage
Title
Cited by
Cited by
Year
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia
M Mesulam, A Wicklund, N Johnson, E Rogalski, GC Léger, A Rademaker, ...
Annals of Neurology: Official Journal of the American Neurological …, 2008
5432008
Alzheimer's disease
JAS Lopez, HM González, GC Léger
Handbook of clinical neurology 167, 231-255, 2019
3152019
Dopa decarboxylase activity of the living human brain.
A Gjedde, J Reith, S Dyve, G Leger, M Guttman, M Diksic, A Evans, ...
Proceedings of the National Academy of Sciences 88 (7), 2721-2725, 1991
2021991
Pharmacological treatment of Alzheimer disease
F Massoud, GC Léger
The Canadian Journal of Psychiatry 56 (10), 579-588, 2011
1312011
6-[18F]fluoro-l-DOPA Metabolism in Living Human Brain: A Comparison of Six Analytical Methods
H Hoshi, H Kuwabara, G Léger, P Cumming, M Guttman, A Gjedde
Journal of Cerebral Blood Flow & Metabolism 13 (1), 57-69, 1993
1201993
Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to …
H Kuwabara, P Cumming, J Reith, G Leger, M Diksic, AC Evans, ...
Journal of Cerebral Blood Flow & Metabolism 13 (1), 43-56, 1993
1191993
Striatal L‐dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis
A Gjedde, GC Léger, P Cumming, Y Yasuhara, AC Evans, M Guttman, ...
Journal of neurochemistry 61 (4), 1538-1541, 1993
901993
Pharmacokinetics of Plasma 6-[18F]Fluoro-l-3,4-Dihydroxyphenylalanine ([18F]FDOPA) in Humans
P Cumming, GC Léger, H Kuwabara, A Gjedde
Journal of Cerebral Blood Flow & Metabolism 13 (4), 668-675, 1993
871993
Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease
H Kuwabara, P Cumming, Y Yasuhara, GC Léger, M Guttman, M Diksic, ...
Journal of Nuclear Medicine 36 (7), 1226-1231, 1995
601995
Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
M Guttman, G Leger, A Reches, A Evans, H Kuwabara, JM Cedarbaum, ...
Movement disorders: official journal of the Movement Disorder Society 8 (3 …, 1993
511993
Correction for partial volume effects in PET using MRI-based 3-D simulations of individual human brain metabolism
OG Rousset, Y Ma, GC Leger, AH Gjedde, AC Evans
Annals of Nuclear Medicine 7 (SUPPL. 1), S31-S32, 1993
491993
3‐O‐methyldopa administration does not alter fluorodopa transport into the brain
M Guttman, G Léger, JM Cedarbaum, A Reches, W Woodward, A Evans, ...
Annals of Neurology: Official Journal of the American Neurological …, 1992
491992
Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia
GC Léger, SJ Banks
Dementia and geriatric cognitive disorders 37 (1-2), 104-112, 2014
482014
Reduction of Circulating 3-O-Methyldopa by Inhibition of Gatechol-O-Methyltransferase With OR-611 and OR-462 in Cynomolgus Monkeys: Implications for the Treatment of Parkinson …
JM Cedarbaum, G Leger, M Guttman
Clinical neuropharmacology 14 (4), 330-342, 1991
461991
Structural and functional MRI differences in master sommeliers: a pilot study on expertise in the brain
SJ Banks, KR Sreenivasan, DM Weintraub, D Baldock, M Noback, ...
Frontiers in Human Neuroscience, 414, 2016
382016
Toward a revision of criteria for the dementias
K Rockwood, RW Bouchard, R Camicioli, G Léger
Alzheimer's & Dementia 3 (4), 428-440, 2007
382007
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3 …
DK Burns, RC Alexander, KA Welsh-Bohmer, M Culp, C Chiang, J O’Neil, ...
The Lancet Neurology 20 (7), 537-547, 2021
302021
Relationship between the activities of daily living questionnaire and the montreal cognitive assessment
J Durant, GC Leger, SJ Banks, JB Miller
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 4, 43-46, 2016
302016
A Systematic review of positron emission tomography of tau, amyloid beta, and neuroinflammation in chronic traumatic encephalopathy: the evidence to date
BG Lee, MKJ Leavitt, CB Bernick, GC Leger, G Rabinovici, SJ Banks
Journal of Neurotrauma 35 (17), 2015-2024, 2018
272018
Comparing the electronic and standard versions of the Montreal Cognitive Assessment in an outpatient memory disorders clinic: a validation study
JL Berg, J Durant, GC Léger, JL Cummings, Z Nasreddine, JB Miller
Journal of Alzheimer's Disease 62 (1), 93-97, 2018
272018
The system can't perform the operation now. Try again later.
Articles 1–20